Hodgkin lymphoma survival has nearly tripled since the 1950sJanuary 30, 2017Indolent LymphomaAggressive LymphomasHodgkin Lymphoma
Hepatitis infection raises non-Hodgkin lymphoma risk in HIV patientsOctober 17, 2016Aggressive LymphomasHodgkin Lymphoma
Pembrolizumab shows signs of efficacy in relapsed/refractory classical Hodgkin lymphomaJuly 5, 2016Aggressive LymphomasHodgkin Lymphoma
Adding obinutuzumab to bendamustine boosts progression-free survival in rituximab-refractory indolent non-Hodgkin lymphomaJune 28, 2016Indolent LymphomaHodgkin Lymphoma
‘Impressive’ responses with nivolumab in relapsed Hodgkin lymphomaJune 16, 2016Aggressive LymphomasHodgkin Lymphoma
Brentuximab vedotin boosted PET-negative rate in HodgkinJune 6, 2016Indolent LymphomaHodgkin Lymphoma
FDA grants accelerated approval to nivolumab for Hodgkin lymphomaMay 17, 2016Aggressive LymphomasHodgkin Lymphoma
Low transformation rate in nodular lymphocyte–predominant Hodgkin lymphomaApril 28, 2016Indolent LymphomaHodgkin Lymphoma
FDG-PET guides need for eBEACOPP in advanced Hodgkin’sApril 12, 2016Indolent LymphomaAggressive LymphomasHodgkin Lymphoma
Concerning number of HIV-associated Hodgkin lymphoma patients go untreatedJanuary 18, 2016Hodgkin Lymphoma
Pregnancy did not increase Hodgkin lymphoma relapse rateDecember 14, 2015Aggressive LymphomasPatient & Survivor CareHodgkin Lymphoma
Medical Roundtable: Pediatric Non-Hodgkin Lymphoma (NHL) Classification Guidelines - International Pediatric NHL Staging System (IPNHLSS)November 25, 2015Aggressive LymphomasHodgkin Lymphoma
Medical Roundtable: Hodgkin Lymphoma - Discussing Recent Evidence & Practice OptionsOctober 19, 2015Indolent LymphomaAggressive LymphomasHodgkin Lymphoma
Interim PET results guide ongoing therapy in Hodgkin lymphomaJuly 8, 2015Indolent LymphomaHodgkin Lymphoma
